Robert P Giugliano Selected Research

Hemorrhagic Stroke

1/2021	Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
1/2020	Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis.
1/2018	Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis.
1/2018	Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial.
12/2017	Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
8/2017	Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials.
1/2017	Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial.
2/2016	Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial.
8/2014	Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.
2/2013	Novel oral anticoagulants in atrial fibrillation: a meta-analysis of large, randomized, controlled trials vs warfarin.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert P Giugliano Research Topics

Disease

130	Myocardial Infarction 03/2022 - 06/2002
97	Atrial Fibrillation 09/2022 - 10/2010
94	Stroke (Strokes) 09/2022 - 04/2005
89	Hemorrhage 09/2022 - 04/2003
72	Acute Coronary Syndrome 01/2022 - 01/2003
46	ST Elevation Myocardial Infarction 01/2022 - 07/2002
41	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 06/2002
33	Embolism (Embolus) 09/2022 - 10/2010
21	Unstable Angina 03/2022 - 06/2002
20	Ischemic Stroke 12/2021 - 07/2011
16	Thrombosis (Thrombus) 11/2019 - 12/2004
15	Heart Failure 01/2022 - 12/2002
15	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2005
12	Infarction (Infarctions) 01/2022 - 09/2003
12	Diabetes Mellitus 01/2021 - 08/2013
12	Ischemia 01/2018 - 02/2004
11	Hemorrhagic Stroke 01/2021 - 09/2011
10	Coronary Disease (Coronary Heart Disease) 01/2022 - 09/2008
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2021 - 04/2003
9	Thromboembolism 01/2019 - 10/2010
8	Hypercholesterolemia 07/2022 - 06/2011
8	Atherosclerosis 03/2022 - 10/2010
8	Hypertension (High Blood Pressure) 01/2022 - 02/2005
8	Venous Thromboembolism 01/2020 - 09/2011
7	Body Weight (Weight, Body) 01/2022 - 05/2009
7	Non-ST Elevated Myocardial Infarction 01/2022 - 06/2002
6	Peripheral Arterial Disease 09/2022 - 03/2016
6	Neoplasms (Cancer) 01/2022 - 01/2017
5	Transient Ischemic Attack 11/2020 - 08/2014
4	Reperfusion Injury 04/2016 - 11/2009
3	Aortic Valve Stenosis (Aortic Stenosis) 09/2020 - 03/2017
3	Renal Insufficiency (Renal Failure) 01/2020 - 05/2008
3	Heart Valve Diseases (Valvular Heart Disease) 01/2018 - 03/2017
3	Obesity 08/2014 - 12/2012

Drug/Important Bio-Agent (IBA)

79	Warfarin (Coumadin)FDA LinkGeneric 09/2022 - 11/2009
56	edoxabanIBA 09/2022 - 10/2010
53	AnticoagulantsIBA 02/2022 - 06/2007
42	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022 - 09/2008
38	LDL CholesterolIBA 01/2022 - 09/2008
35	evolocumabIBA 07/2022 - 01/2012
35	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 10/2010
30	oxidized low density lipoproteinIBA 07/2022 - 09/2008
28	Vitamin K FDA Link 02/2022 - 10/2010
25	Glycoproteins (Glycoprotein)IBA 01/2020 - 02/2004
22	Ezetimibe (Zetia)FDA Link 01/2022 - 08/2014
19	Eptifibatide (Integrilin)FDA Link 04/2017 - 04/2003
15	LipidsIBA 03/2022 - 09/2008
15	Simvastatin (Zocor)FDA LinkGeneric 10/2021 - 11/2008
14	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 05/2006
14	Pharmaceutical PreparationsIBA 11/2020 - 06/2003
13	CreatinineIBA 01/2022 - 12/2002
13	Clopidogrel (Plavix)FDA Link 01/2022 - 07/2006
13	Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link 10/2021 - 11/2008
12	Factor Xa InhibitorsIBA 03/2019 - 10/2010
11	Proprotein Convertase 9IBA 01/2022 - 08/2013
11	Enoxaparin (Lovenox)FDA LinkGeneric 07/2013 - 06/2002
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2004
9	N(4)-oleylcytosine arabinosideIBA 01/2021 - 08/2014
9	Tenecteplase FDA Link 07/2009 - 04/2003
8	CholesterolIBA 01/2022 - 01/2012
7	N(2)-(3-trifluoromethylphenyl)guanineIBA 04/2014 - 05/2004
7	Prasugrel Hydrochloride FDA Link 11/2013 - 03/2009
7	Heparin (Liquaemin)FDA LinkGeneric 07/2009 - 01/2003
6	TicagrelorIBA 01/2022 - 01/2010
6	eicosapentaenoic acid ethyl esterIBA 01/2022 - 01/2020
6	TroponinIBA 01/2022 - 12/2004
6	AntithrombinsIBA 04/2018 - 08/2004
5	RivaroxabanIBA 01/2022 - 09/2013
5	Lipoprotein(a)IBA 01/2022 - 08/2013
5	Tirofiban (Aggrastat)FDA Link 11/2020 - 02/2004
5	Dabigatran FDA Link 01/2018 - 09/2011
5	MB Form Creatine KinaseIBA 04/2016 - 09/2003
4	apixabanIBA 02/2022 - 08/2014
4	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 04/2017
4	Monoclonal AntibodiesIBA 01/2022 - 01/2012
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 01/2013
4	HDL CholesterolIBA 01/2020 - 10/2011
4	Hemoglobins (Hemoglobin)IBA 01/2019 - 04/2005
4	Glucose (Dextrose)FDA LinkGeneric 04/2017 - 01/2012
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2016 - 01/2003
4	Platelet Membrane Glycoprotein IIbIBA 01/2012 - 01/2008
3	omega-Chloroacetophenone (Mace)IBA 03/2022 - 12/2019
3	C-Reactive ProteinIBA 01/2022 - 10/2018
3	Growth Differentiation Factor 15IBA 01/2021 - 10/2010
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 08/2014
3	HDL LipoproteinsIBA 01/2020 - 08/2014
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2007
3	arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA 04/2016 - 04/2013
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2014 - 03/2009
2	ApolipoproteinsIBA 03/2022 - 11/2016
2	Lipoproteins (Lipoprotein)IBA 03/2022 - 01/2022

Therapy/Procedure

93	Therapeutics 03/2022 - 04/2003
34	Percutaneous Coronary Intervention 01/2018 - 01/2003
17	Thrombolytic Therapy 04/2011 - 01/2003
8	Secondary Prevention 01/2022 - 01/2013
7	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 07/2007
6	Drug Tapering 01/2019 - 05/2012
5	Patient Readmission 06/2015 - 02/2004
5	Stents 10/2014 - 03/2011
3	Drug-Eluting Stents 03/2011 - 06/2003